Literature DB >> 19881266

Dynamic influence of the two membrane-proximal immunoglobulin-like domains upon the peptide-binding platform domain in class I and class II major histocompatibility complexes: normal mode analysis.

Hiroyuki Nojima1, Kazuhiko Kanou, Kenshu Kamiya, Koichiro Atsuda, Hideaki Umeyama, Mayuko Takeda-Shitaka.   

Abstract

Major histocompatibility complexes (MHCs) mainly fall into class I and class II. The two classes have similar structures, with two membrane-proximal immunoglobulin-like domains and a peptide-binding platform domain, though their organizations are different. We simulated the dynamics of a whole and partial model deficient in either of the two membrane-proximal domains for class I and class II using normal mode analysis. Our study showed that the influence of the two membrane-proximal domains upon the dynamics of the platform domain were decisively different between class II and class I. Both membrane-proximal domains (the alpha2 and beta2 domains) of class II MHC, especially the alpha2 domain, influenced the most important pocket that accommodates a large hydrophobic anchor side chain of the N-terminal side of the bound peptide, though the pocket was not in the alpha2 domain neighborhood. By contrast, the two membrane-proximal domains (the alpha3 and beta2m domains) of class I MHC had little influence upon the most important pocket that accommodates the N-terminal residue of the bound peptide. These results suggest that the two membrane-proximal domains of class II MHC have a greater influence upon peptide-binding than those of class I MHC.

Mesh:

Substances:

Year:  2009        PMID: 19881266     DOI: 10.1248/cpb.57.1193

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  Cholesterol lowering drug may influence cellular immune response by altering MHC II function.

Authors:  Koushik Roy; Moumita Ghosh; Tuhin Kumar Pal; Saikat Chakrabarti; Syamal Roy
Journal:  J Lipid Res       Date:  2013-09-13       Impact factor: 5.922

Review 2.  Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.

Authors:  Marek Wieczorek; Esam T Abualrous; Jana Sticht; Miguel Álvaro-Benito; Sebastian Stolzenberg; Frank Noé; Christian Freund
Journal:  Front Immunol       Date:  2017-03-17       Impact factor: 7.561

3.  Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring.

Authors:  Tanja Scheikl-Gatard; Caroline Tosch; François Lemonnier; Ronald Rooke
Journal:  J Transl Med       Date:  2017-07-05       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.